Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat

Abrogation of Anti-HLA Antibodies via Proteasome Inhibition

(2009) Hargovind L. Trivedi et al.   TRANSPLANTATION

Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production

(2008) D. K. Perry et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions

(2008) K. Solez et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade)

(2008) M Arpinati et al.   BONE MARROW TRANSPLANTATION

Proteasome inhibition drastically but reversibly impairs murine lymphocyte development

(2008) D Maseda et al.   CELL DEATH AND DIFFERENTIATION

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE

Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model

(2008) Martina Koch et al.   TRANSPLANT IMMUNOLOGY

Effects of Immunosuppressive Drugs On Purified Human B Cells: Evidence Supporting the Use of MMF and Rapamycin

(2008) Sebastiaan Heidt et al.   TRANSPLANTATION

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

(2008) Matthew J. Everly et al.   TRANSPLANTATION

Antibody-mediated rejection: treatment alternatives and outcomes

(2008) Neeraj Singh et al.   Transplantation Reviews